PRECIPIO, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
PRECIPIO, INC. (PRPO) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price of $10.60 per share for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-16.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2015-11-16
- PRECIPIO, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2015-03-31 was $10.20.
- PRECIPIO, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2013-03-31 was $0.00.
- PRECIPIO, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2012 was $5.42, a 18.98% decline from fiscal 2011.
- PRECIPIO, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2011 was $6.69, a 39.57% decline from fiscal 2010.
- PRECIPIO, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2010 was $11.07.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2015-09-30 | $10.60 10-Q · filed 2015-11-16 | |||
| 2015-06-30 | $9.99 10-Q · filed 2015-08-14 | |||
| 2015-03-31 | $10.20 10-Q · filed 2015-05-14 | |||
| 2013-09-30 | $1.66 10-Q · filed 2013-11-14 | |||
| 2013-06-30 | $1.66 10-Q · filed 2013-08-08 | |||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-09 | |||
| 2012-12-31 | $5.42 10-K · filed 2013-03-14 | |||
| 2012-09-30 | $5.42 10-Q · filed 2012-11-08 | |||
| 2012-06-30 | $5.73 10-Q · filed 2012-08-02 | |||
| 2011-12-31 | $6.69 10-K · filed 2013-03-14 | |||
| 2010-12-31 | $11.07 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |